Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-053560

EVP, Research & CSO sold 2,750 shares at $50.00 ($137,500)

  • EVP, Research & CSO acquired 2,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-08-25 Option exercise +2,750 $1.53 $4,208 102,450 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2021-08-25 Sale −2,750 $50.00 $137,500 99,700 D: show line 2 in the form
Open-market sales · 2,750 sh · avg $50.00 · $137,500

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-08-25 Option exercise · Stock Option (Right to Buy) −2,750 267,380 D: show line 3 in the form
Loading xslF345X03/doc4.xml…